Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: A cohort study using an institutional joint registry

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Singh, Jasvinder A ^a,b,c   Lewallen, David G ^c  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; STEROID; ANALGESIC AGENT;

ADULT; AGED; ALDRETE SCORE; AMERICAN SOCIETY OF ANESTHESIOLOGIST SCORE; ANXIETY DISORDER; ARTICLE; BODY MASS; BONE PLATE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DEYO CHARLSON INDEX; DISEASE REGISTRY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; GROUPS BY AGE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MAYO TOTAL JOINT REGISTRY; PAIN ASSESSMENT; PREDICTOR VARIABLE; PREVALENCE; RATING SCALE; RISK FACTOR; SEX DIFFERENCE; SURGICAL PATIENT; SURGICAL TECHNIQUE; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; ADVERSE EFFECTS; ANXIETY; ARTHRALGIA; CHEMICALLY INDUCED; DRUG EFFECTS; FOLLOW UP; KNEE; KNEE ARTHROPLASTY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; REGISTER; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANXIETY; ARTHRALGIA; ARTHROPLASTY, REPLACEMENT, KNEE; BODY MASS INDEX; COHORT STUDIES; DEPRESSION; FOLLOW-UP STUDIES; HUMANS; KNEE JOINT; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REGISTRIES;

EID: 84869036324     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4091     Document Type: Article

References (36)

1. Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004, 86-A:963-974.
2. Singh JA, Gabriel S, Lewallen D. The impact of gender, age, and preoperative pain severity on pain after TKA. Clin Orthop Relat Res 2008, 466:2717-2723. 10.1007/s11999-008-0399-9, 2565033, 18679762.
3. Bolland BJ, Culliford DJ, Maskell J, Latham JM, Dunlop DG, Arden NK. The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database. Osteoarthritis Cartilage 2011, 19:29-36. 10.1016/j.joca.2010.10.012, 21034838.
4. Franklin PD, Karbassi JA, Li W, Yang W, Ayers DC. Reduction in narcotic use after primary total knee arthroplasty and association with patient pain relief and satisfaction. J Arthroplasty 2010, 25:12-16. 10.1016/j.arth.2010.05.003, 20580191.
5. Gregorian RS, Gasik A, Kwong WJ, Voeller S, Kavanagh S. Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians. J Pain 2010, 11:1095-1108. 10.1016/j.jpain.2010.02.007, 20452835.
6. Lapane KL, Spooner JJ, Mucha L, Straus WL. Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care. J Am Geriatr Soc 2001, 49:577-584. 10.1046/j.1532-5415.2001.49117.x, 11380750.
7. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995, 141:539-545.
8. Boulanger L, Zhao Y, Foster TS, Fraser K, Bledsoe SL, Russell MW. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain. Curr Med Res Opin 2009, 25:1763-1773. 10.1185/03007990902997309, 19505204.
9. Le TK, Able SL, Lage MJ. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc 2006, 4:18. 10.1186/1478-7547-4-18, 1629026, 17059602.
10. Singh JA, Lewallen D. Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years. BMC Musculoskelet Disord 2010, 11:90. 10.1186/1471-2474-11-90, 2881019, 20462458.
11. STROBE Statement. Strengthening the reporting of observational studies in epidemiology. , http://www.strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_cohort.pdf
12. Rand JA, Ilstrup DM. Survivorship analysis of total knee arthroplasty. Cumulative rates of survival of 9200 total knee arthroplasties. J Bone Joint Surg Am 1991, 73:397-409.
13. Rand JA, Trousdale RT, Ilstrup DM, Harmsen WS. Factors affecting the durability of primary total knee prostheses. J Bone Joint Surg Am 2003, 85-A:259-265.
14. McGrory BJ, Morrey BF, Rand JA, Ilstrup DM. Correlation of patient questionnaire responses and physician history in grading clinical outcome following hip and knee arthroplasty. A prospective study of 201 joint arthroplasties. J Arthroplasty 1996, 11:47-57. 10.1016/S0883-5403(96)80160-4, 8676118.
15. Singh JA, O'Byrne MM, Colligan RC, Lewallen DG. Pessimistic explanatory style: A psychological risk factor for poor pain and functional outcomes two years after knee replacement. J Bone Joint Surg Br 2010, 92:799-806.
16. Singh JA, O'Byrne MM, Harmsen WS, Lewallen DG. Predictors of moderate-severe functional limitation 2 and 5 years after revision total knee arthroplasty. J Arthroplasty 2010, 25:1091-1095. 10.1016/j.arth.2009.07.020, 20888546.
17. Singh JA, O'Byrne M, Harmsen S, Lewallen D. Predictors of moderate-severe functional limitation after primary Total Knee Arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years. Osteoarthritis Cartilage 2010, 18:515-521. 10.1016/j.joca.2009.12.001, 20060950.
18. Bourne R, Mukhi S, Zhu N, Keresteci M, Marin M. Role of obesity on the risk for total hip or knee arthroplasty. Clin Orthop Relat Res 2007, 465:185-188.
19. WHO Obesity: preventing and managing the global epidemic. 2000, Geneva: World Health Organization, WHO.
20. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619. 10.1016/0895-4356(92)90133-8, 1607900.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
22. Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG. Morbidity during hospitalization: can we predict it?. J Chronic Dis 1987, 40:705-712. 10.1016/0021-9681(87)90107-X, 3110198.
23. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961, 178:261-266. 10.1001/jama.1961.03040420001001, 13887881.
24. Brander VA, Stulberg SD, Adams AD, Harden RN, Bruehl S, Stanos SP, Houle T. Predicting total knee replacement pain: a prospective, observational study. Clin Orthop Relat Res 2003, 27-36.
25. Lingard EA, Riddle DL. Impact of psychological distress on pain and function following knee arthroplasty. J Bone Joint Surg Am 2007, 89:1161-1169. 10.2106/JBJS.F.00914, 17545417.
26. Brander V, Gondek S, Martin E, Stulberg SD. Pain and depression influence outcome 5 years after knee replacement surgery. Clin Orthop Relat Res 2007, 464:21-26.
27. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002, 287:337-344. 10.1001/jama.287.3.337, 11790213.
28. Antonov K, Isacson D. Use of analgesics in Sweden--the importance of sociodemographic factors, physical fitness, health and health-related factors, and working conditions. Soc Sci Med 1996, 42:1473-1481. 10.1016/0277-9536(96)87321-7, 8771630.
29. Hall S, Gallagher RM, Gracely E, Knowlton C, Wescules D. The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose. Pain Med 2003, 4:125-134. 10.1046/j.1526-4637.2003.03020.x, 12873262.
30. Honari S, Patterson DR, Gibbons J, Martin-Herz SP, Mann R, Gibran NS, Heimbach DM. Comparison of pain control medication in three age groups of elderly patients. J Burn Care Rehabil 1997, 18:500-504. 10.1097/00004630-199711000-00006, 9404983.
31. Maas HJ, Danhof M, Della Pasqua OE. Analysis of the relationship between age and treatment response in migraine. Cephalalgia 2009, 29:772-780. 10.1111/j.1468-2982.2008.01823.x, 19281474.
32. Likar R, Vadlau EM, Breschan C, Kager I, Korak-Leiter M, Ziervogel G. Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age. Clin J Pain 2008, 24:536-543. 10.1097/AJP.0b013e3181673b65, 18574363.
33. Haskell SG, Heapy A, Reid MC, Papas RK, Kerns RD. The prevalence and age-related characteristics of pain in a sample of women veterans receiving primary care. J Womens Health (Larchmt) 2006, 15:862-869.
34. Jones JS, Johnson K, McNinch M. Age as a risk factor for inadequate emergency department analgesia. Am J Emerg Med 1996, 14:157-160. 10.1016/S0735-6757(96)90123-0, 8924137.
35. Singh JA, Gabriel SE, Lewallen DG. Higher body mass index is not associated with worse pain outcomes after primary or revision total knee arthroplasty. J Arthroplasty 2011, 26:366-374. e361, 10.1016/j.arth.2010.02.006, 2930933, 20413245.
36. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997, 50:1129-1136. 10.1016/S0895-4356(97)00126-1, 9368521.